Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A L Miller

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|September 13, 2005
Statins--challenges and provocationsJames A L Miller
Intensive Care Medicine|March 22, 2006
Statins for sepsis: a cautionary noteAngus Vincent, James A L Miller
Neurology|June 25, 2014
Teaching video neuroimages: muscle cramps and a raised creatine kinaseRoger G Whittaker, Patrick F Chinnery, James A L Miller
Practical Neurology|January 25, 2022
Delivering an advice and guidance service in neurologyKirstie N Anderson, Naomi Warren, Martin Duddy, et al.
Muscle & Nerve|March 6, 2020
Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroupsAlexander G S Oldroyd, James B Lilleker, Jacob Williams, et al.
The Journal of Rheumatology|October 10, 2008
Alemtuzumab (Campath-1H) for treatment of refractory polymyositisBen Thompson, Paul Corris, James A L Miller, et al.
Clinical and Experimental Rheumatology|March 2, 2023
Two emerging phenotypes of atypical inclusion body myositis: illustrative casesSharfaraz Salam, Jasper M Morrow, Robin Howard, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsyJames A L Miller, Achillefs Spyropoulos, Evelyn Jaros, et al.
Muscle & Nerve|June 24, 2011
Sodium and chloride channelopathies with myositis: coincidence or connection?Emma Matthews, James A L Miller, Malcolm R MacLeod, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|September 13, 2005
Statins--challenges and provocationsJames A L Miller
Intensive Care Medicine|March 22, 2006
Statins for sepsis: a cautionary noteAngus Vincent, James A L Miller
Neurology|June 25, 2014
Teaching video neuroimages: muscle cramps and a raised creatine kinaseRoger G Whittaker, Patrick F Chinnery, James A L Miller
Practical Neurology|January 25, 2022
Delivering an advice and guidance service in neurologyKirstie N Anderson, Naomi Warren, Martin Duddy, et al.
Muscle & Nerve|March 6, 2020
Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroupsAlexander G S Oldroyd, James B Lilleker, Jacob Williams, et al.
The Journal of Rheumatology|October 10, 2008
Alemtuzumab (Campath-1H) for treatment of refractory polymyositisBen Thompson, Paul Corris, James A L Miller, et al.
Clinical and Experimental Rheumatology|March 2, 2023
Two emerging phenotypes of atypical inclusion body myositis: illustrative casesSharfaraz Salam, Jasper M Morrow, Robin Howard, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsyJames A L Miller, Achillefs Spyropoulos, Evelyn Jaros, et al.
Muscle & Nerve|June 24, 2011
Sodium and chloride channelopathies with myositis: coincidence or connection?Emma Matthews, James A L Miller, Malcolm R MacLeod, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Pageof 2